Susanne Hedbom

Statistics

Publications

Citations

575

H-Index

Active since

2008

Affiliations

Boehringer Ingelheim (Germany)(Current)

Susanne Hedbom is an author at Boehringer Ingelheim (Germany) specializing in cancer pharmacology, pharmacokinetics of anticancer drugs, and oncology.

Publications per year

2008–2012

Publications

A Phase I Dose–Escalation Study of Regorafenib (BAY 73–4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors

K. Mross, Annette Frost, Simone Steinbild et al. · Clinical Cancer Research · 2012 · 333 citations

Medicine, Oncology, Pharmacology +17

Phase I Dose Escalation and Pharmacokinetic Study of BI 2536, a Novel Polo-Like Kinase 1 Inhibitor, in Patients With Advanced Solid Tumors

K. Mross, Annette Frost, Simone Steinbild et al. · Journal of Clinical Oncology · 2008 · 158 citations · Full text

Pharmacy, Oncology, Pharmacology +14

Phase I Study of the Plk1 Inhibitor BI 2536 Administered Intravenously on Three Consecutive Days in Advanced Solid Tumours

Annette Frost, K. Mross, Simone Steinbild et al. · Current Oncology · 2012 · 84 citations · Full text

Pharmacy, Oncology, Pharmacology +14

1–3 of 3